Fennec Pharmaceuticals (FENC) Stock Chart & Stock Price History $6.30 +0.19 (+3.11%) Closing price 04:00 PM EasternExtended Trading$6.54 +0.24 (+3.79%) As of 06:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Fennec Pharmaceuticals Stock Price Performance 5 Day Performance+11.90%1 Month Performance+6.06%3 Month Performance-3.08%6 Month Performance+45.16%Year-To-Date Performance-0.32%1 Year Performance-30.69% Receive FENC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address FENC Stock Chart for Friday, May, 2, 2025 FENC Chart by TradingView Fennec Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/02/2025$6.11$6.30+3.11%$6.48$6.0463,295 shs$173.84 million05/01/2025$6.04$6.11+1.16%$6.23$5.7866,466 shs$168.60 million04/30/2025$6.19$6.04-2.42%$6.37$5.9166,367 shs$166.67 million04/29/2025$6.01$6.19+3.00%$6.27$5.9541,703 shs$170.81 million04/28/2025$5.63$6.01+6.75%$6.04$5.5849,657 shs$165.84 million04/25/2025$5.69$5.63-1.05%$5.75$5.5422,746 shs$155.35 million04/24/2025$5.65$5.69+0.71%$5.72$5.5146,685 shs$157.01 million04/23/2025$5.44$5.65+3.86%$5.75$5.5339,983 shs$155.91 million04/22/2025$5.21$5.44+4.41%$5.51$5.1743,572 shs$150.11 million04/21/2025$5.08$5.21+2.56%$5.31$5.0253,536 shs$143.77 million Get the Latest News and Ratings for FENC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/18/2025$5.08$5.08$5.16$5.0338,380 shs$140.18 million04/17/2025$5.10$5.08-0.39%$5.16$5.0338,380 shs$140.18 million04/16/2025$5.25$5.10-2.86%$5.31$5.0233,451 shs$140.73 million04/15/2025$5.27$5.25-0.38%$5.50$5.1866,256 shs$144.87 million04/14/2025$5.01$5.27+5.19%$5.36$4.9854,065 shs$145.42 million04/11/2025$5.01$5.01$5.07$4.9351,179 shs$138.22 million04/10/2025$5.06$5.01-0.99%$5.20$4.8790,584 shs$138.22 million04/09/2025$5.01$5.06+1.00%$5.26$4.68166,720 shs$139.60 million04/09/2025$5.01$5.06+1.00%$5.26$4.68166,720 shs$139.60 million04/08/2025$5.21$5.01-3.84%$5.51$4.86161,977 shs$138.22 million04/08/2025$5.21$5.01-3.84%$5.51$4.86161,977 shs$138.22 million04/07/2025$5.25$5.21-0.76%$5.54$5.00109,722 shs$143.73 million04/04/2025$5.59$5.25-6.08%$5.61$5.10172,838 shs$144.84 million04/03/2025$5.94$5.59-5.89%$5.89$5.5659,298 shs$154.22 million04/02/2025$5.53$5.94+7.41%$5.96$5.5081,936 shs$163.87 million04/01/2025$6.09$5.53-9.20%$6.11$5.4792,710 shs$152.56 million Related Companies VectivBio Stock Price Chart Valneva Stock Price Chart Opthea Stock Price Chart Immatics Stock Price Chart Cullinan Therapeutics Stock Price Chart Relay Therapeutics Stock Price Chart MeiraGTx Stock Price Chart Tourmaline Bio Stock Price Chart Ginkgo Bioworks Stock Price Chart Maze Therapeutics Stock Price Chart Receive FENC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:FENC) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fennec Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Fennec Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
